40 mg Darbepoetin Alfa Injection

Product Description

40 mg Darbepoetin Alfa Injection is a synthetic form of erythropoietin, a hormone that stimulates red blood cell production. It stimulates the bone marrow to produce red blood cells, addressing anemia resulting from impaired erythropoietin production in CKD patients. This is used to treat anemia in cancer patients undergoing chemotherapy for non-myeloid malignancies. It is primarily used to treat anemia associated with chronic kidney disease (CKD) and chemotherapy-induced anemia. 40 mg Darbepoetin Alfa Injection improves hemoglobin levels, reduces the need for blood transfusions, and helps improve quality of life by reducing fatigue and weakness associated with anemia

Product Type - Darbepoetin Alfa Injection

Self Life - 1.5 To 2 Years 

Usage - Commercial